Oregon Public Employees Retirement Fund’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,857	Closed	-$329K	–	1608
2021 Q1	$329K	Hold	12,857	–	–	﹤0.01%	1443
2020 Q4	$283K	Sell	12,857 -2,443	-16%	-$53.8K	﹤0.01%	1425
2020 Q3	$275K	Buy	15,300 +3,527	+30%	+$73K	﹤0.01%	1330
2020 Q2	$299K	Sell	11,773 -5,200	-31%	-$112K	﹤0.01%	1299
2020 Q1	$312K	Hold	16,973	–	–	0.01%	1208
2019 Q4	$374K	Buy	+16,973	New	+$342K	0.01%	1309

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oregon Public Employees Retirement Fund's DRNA Position: Q2 2021 in Review

Oregon Public Employees Retirement Fund sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2021, closing a stake of 12,857 shares — an estimated $329K sold.

Oregon Public Employees Retirement Fund first reported a position in DRNA in Q4 2019 and held it in 6 quarters. The position peaked at $374K in Q4 2019. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

Oregon Public Employees Retirement Fund reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 12,857 Dicerna Pharmaceuticals, Inc. shares in Q2 2021, an estimated $329K.
Oregon Public Employees Retirement Fund first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
Oregon Public Employees Retirement Fund's Dicerna Pharmaceuticals, Inc. position peaked at $374K in Q4 2019.
203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2021, filed 23 Jul 2021.